Editas CEO Katrine Bosley Predicts First CRISPR Human Trial in 2017 | MIT Technology Review

Home / Blog / Editas CEO Katrine Bosley Predicts First CRISPR Human Trial in 2017 | MIT Technology Review
Propell Deal Update